Add BrightSurf on Google Email

The Lancet


Promise of more accurate test for tuberculosis

A new rapid blood test, ELISPOT, developed by Ajit Lalvani and colleagues at the University of Oxford is more effective than the century-old skin-prick test for diagnosing TB infection. The test enables early detection of people infected with TB, preventing them from developing active tuberculosis.

SourceThe Lancet_DELETED·JournalThe Lancet·DateApr 3, 2003

Statins could reduce risk of cardiovascular disease

A new study found that statins can significantly reduce the risk of cardiovascular disease in people with high blood pressure and normal or low cholesterol levels. The treatment resulted in a 36% lower risk of primary events such as death from CHD and non-fatal heart attacks, primarily within the first year of treatment.

SourceThe Lancet_DELETED·JournalThe Lancet·DateApr 2, 2003

The casualties of war

The Lancet editorial emphasizes the importance of addressing health disparities in global conflicts. Experts highlight the need for international cooperation to mitigate the devastating effects of war on vulnerable populations.

SourceThe Lancet_DELETED·JournalThe Lancet·DateMar 27, 2003

Is primary-care research a lost cause?

Researchers argue that primary care is misunderstood by academia and funding bodies, lacking a clear boundary to establish its distinct knowledge base. The editorial disagrees, emphasizing the importance of family practice in influencing all clinical specialties.

SourceThe Lancet_DELETED·JournalThe Lancet·DateMar 20, 2003

Taking the sting out of ant stings

A study found that venom immunotherapy significantly reduced the risk of severe systemic reactions to jack jumper ant stings in healthy adults. The treatment was effective in preventing life-threatening reactions, even in those who had previously experienced severe symptoms.

SourceThe Lancet_DELETED·JournalThe Lancet·DateMar 19, 2003

'Pro-life' policy threatens US HIV/AIDS initiative

The Bush administration is considering implementing a pro-life policy that would restrict foreign non-governmental organizations from receiving US funds if they provide abortions or lobby for abortion liberalization. This policy threatens the $15 billion HIV/AIDS fund, which relies on local clinics providing family-planning and materna...

SourceThe Lancet_DELETED·JournalThe Lancet·DateMar 13, 2003

Prostate cancer series

The Prostate Cancer Series assesses the epidemiology of prostate cancer, highlighting the impact of genetic and environmental risk factors. Despite progress in understanding diet-related risks, familial clustering, and ethnic variation remain poorly understood, presenting opportunities for further research.

SourceThe Lancet_DELETED·JournalThe Lancet·DateMar 6, 2003

Ethnic bias in leading medical journals

The Lancet Commentary highlights the need for a radical transformation to reverse deeply embedded ethnic biases in leading medical journals. The journals prioritize research from the rich world, neglecting the health priorities of poor countries, and this bias affects the range of public debate.

SourceThe Lancet_DELETED·JournalThe Lancet·DateFeb 27, 2003

Downward trend in UK deaths from CJD

The number of UK deaths from vCJD has been declining, with a stabilization in the rate of mortality. The disease's mortality rate is no longer increasing exponentially, but further confirmation is needed to determine if the epidemic is in permanent decline.

SourceThe Lancet_DELETED·JournalThe Lancet·DateFeb 27, 2003

Call for longer-term use of antidepressants

A meta-analysis of 31 trials involving over 4400 patients found that continuous antidepressant treatment for one to two years significantly reduced depressive relapse rates compared to placebo. The study suggests that many patients remain at risk of recurrence after initial treatment and may benefit from extended medication

SourceThe Lancet_DELETED·JournalThe Lancet·DateFeb 20, 2003

Call for longer-term use of antidepressants

A study published in The Lancet found that treatment for one to two years with antidepressants substantially reduced the likelihood of relapse compared to discontinuing active treatment. The average rate of relapse on placebo was nearly double that of treatment, highlighting the benefits of long-term medication adherence.

SourceThe Lancet_DELETED·JournalThe Lancet·DateFeb 20, 2003

Execution: An unwanted side-effect

The Singleton case has raised concerns about forced medical treatment of the mentally ill and its impact on the death penalty. The US Supreme Court must rule against this practice to restore competence for execution as a medically and ethically untenable dilemma.

SourceThe Lancet_DELETED·JournalThe Lancet·DateFeb 20, 2003

New treatment option for heroin addiction

A new treatment option for heroin addiction has shown a promising 75% success rate in reducing opiate use, according to a recent study. The combination of buprenorphine and intensive psychosocial therapy was found to be effective in preventing relapse and reducing criminal activity among patients.

SourceThe Lancet_DELETED·JournalThe Lancet·DateFeb 20, 2003

Health crisis in Iraq

The Lancet reports a severe decline in Iraq's healthcare infrastructure, exacerbated by the Gulf War and 12 years of economic sanctions. The US military's preparation for chemical and biological warfare has also contributed to the humanitarian disaster.

SourceThe Lancet_DELETED·JournalThe Lancet·DateFeb 20, 2003

Jacuzzi danger?

A man with kidney disease experienced severe abdominal pain after using a whirlpool in a Jacuzzi, highlighting potential health risks. The case study suggests that whirlpooling may cause mechanical injury to the kidneys, particularly under conditions like hypertension or anticoagulation.

SourceThe Lancet_DELETED·JournalThe Lancet·DateFeb 6, 2003